Displaying 1 to 8 of 8 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Ascenta Therapeutics Inc A privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. |
United States | N/A |
||
|
|
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. |
United States | N/A |
||
|
|
DiObex Inc Biotechnology company that develops novel products for the treatment of metabolic disorders. |
United States | 16 Apr 2007 | Series B |
|
|
|
Epitomics Inc |
United States | N/A Active |
||
|
|
GlobeImmune Inc Biopharmaceuticals company. |
United States | N/A |
||
|
|
Portola Pharmaceuticals Inc |
United States | N/A Active |
||
|
|
Revance Therapeutics Inc Develops and commercializes therapeutic products for treating chronic disease and age-related changes to skin and soft tissue. |
United States | 1 Jan 2010 | Series D |
|
|
|
Synacom Technology Inc |
United States | N/A |